Lv1
30 积分 2025-06-12 加入
Lysosomes as mediators of drug resistance in cancer
1个月前
已完结
Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells
3个月前
已完结
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma
3个月前
已完结
Discovery of a molecular glue for EGFR degradation
3个月前
已完结
Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers
3个月前
已完结
The present and future of the Cancer Dependency Map
3个月前
已完结
Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux
3个月前
已完结
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
3个月前
已完结
Overcoming ELDR-mediated cancer cell survival via sphingomyelin-driven TRPML1 inactivation and TFEB suppression
3个月前
已关闭
Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
3个月前
已完结
皖公网安备34019202002308
